The Beekman Group

News, insights, analysis and data

The Beekman Group overview

Stories about The Beekman Group

Picture of the Company

Deal round-up 26/04

Gilde, Omikron, TBG and Athena dig deep.

The Beekman Group contact information

Offices

marker icon530 Fifth Avenue, 23rd Floor, New York, 10036, United States
Showing 1 of 1 The Beekman Group offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMr. Vincent Aiello
Job titleChief Financial Officer
LocationNew York, United States
Emaillock image--------
user imageMr. John G. Troiano
Job titleManaging Partner, Co-Founder and Chief Executive Officer
LocationNew York, United States
Emaillock image------
user imageMr. James H. Clippard
Job titleManaging Director
LocationNew York, United States
Emaillock image-------
user imageMr. Jonathan Kelemen
Job titleManaging Director
LocationNew York, United States
Emaillock image-----

The Beekman Group funds managed

Funds in market: 1

FundFund sizeOpen dateStrategy
Fund sizelock image-----
Open dateAug 2023
Strategylock image-----------

Closed funds: 5

FundFund sizeClose dateStrategy
Fund sizelock image--------
Close dateMar 2025
Strategylock image------
Fund sizelock image-------
Close dateJun 2018
Strategylock image---------
Fund sizelock image-----
Close dateJan 2015
Strategylock image-----------

Stories that mention The Beekman Group

Side Letter: $5.4bn reasons to repeal

A court has heard oral arguments for and against the SEC's private fund advisers rule. Plus: Hg's retail raise and Arkansas seeks new manager relationships. Here's today's brief, for our valued subscribers only.

Deal round-up 07/04/03

Sovereign leads Principal Schools buyout; Epigenomics lands E21m third round; Apax backs E10m Corvil Networks round; Granville Baird backs German MBO; Granville Baird backs German MBO

Deal round-up 16/05/03

CDC-IXIS, BNP back French software funding; 3i joins electronic design round; VC firms lead Novaled round; European VCs back diagnostics business

TVM raises E336m for life science

The German-US venture capitalist has closed TVM Life Science V well above its initial E250m target, indicating that investor demand for biotech is holding up well.

Mercury leads financing for healthcare service provider

German VTSI has raised E23.7m in its second round of financing. Mercury Private Equity invested alongside DB Investor and Candover.